Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records-Reference-Cited by-同舟云学术

Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records

Published:2021-10 Issue: Volume:Volume 17 Page:3229-3244
ISSN:1178-2021
Container-title:Neuropsychiatric Disease and Treatment
language:en
Short-container-title:NDT

Author:

Ker Sheryl^ORCID,Hsu Jennifer,Balani Anisha,Mukherjee Sankha Subhra^ORCID,Rush A John^ORCID,Khan Mehreen,Elchehabi Sara,Huffhines Seth,DeMoss Dustin,Rentería Miguel E^ORCID,Sarkar Joydeep

Publisher

Informa UK Limited

Reference42 articles.

1. The economic costs of heroin addiction in the United States

2. Treating Drug Abuse and Addiction in the Criminal Justice System

3. Substance Abuse and Mental Health Services Administration. Results from the 2019 National Survey on Drug Use and Health: detailed tables. Available from: https://www.samhsa.gov/data/report/2019-nsduh-detailed-tables. Accessed October 13, 2021.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pain, Substance Use Disorders, Mental Health, and Buprenorphine Treatment among Patients With and Without HIV;AIDS and Behavior;2024-09-12

2. Learning by Doing;The Journal of Clinical Psychiatry;2024-07-17

3. Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder;Journal of Addictive Diseases;2024-06-30

4. Predictability of buprenorphine‐naloxone treatment retention: A multi‐site analysis combining electronic health records and machine learning;Addiction;2024-06-24

5. Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review;International Journal of Drug Policy;2024-05